A UK multi-centre pilot study of speech and swallowing outcomes following head and neck cancer

K. Radford, H. Woods, D. Lowe, S. Rogers

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Speech and swallowing are important components of health-related quality of life following head and neck cancer treatment. The aim of this study was to demonstrate the value of prospective multi-centre evaluation by Speech and Language Therapists and to compare health-related quality of life with speech and swallowing impairments. The University of Washington Head and Neck questionnaire version 4 (UW-QOL) and Therapy Outcome Measures (TOM) were rated before and 6 months after cancer treatment in 95 patients from 12 centres. There was deterioration in TOM scores at 6 months. Pretreatment UW-QOL swallowing was ranked equal first, with speech fourth. At 6 months speech was first and swallowing second. There were positive correlations between UW-QOL swallowing and TOM dysphagia and between UW-QOL speech and TOM laryngectomy, voice, phonology and dysarthria disorders. Both outcome measures are suitable for routine practice. Adaptation of TOM scales for use with head and neck cancer patients may improve sensitivity, validity and therapist compliance.
Original languageEnglish
Pages (from-to)376-381
JournalClinical Otolaryngology & Allied Sciences
Volume29
Issue number4
DOIs
Publication statusPublished - 2004

Fingerprint

Head and Neck Neoplasms
Deglutition
Outcome Assessment (Health Care)
Therapeutics
Quality of Life
Speech Therapy
Dysarthria
Laryngectomy
Deglutition Disorders
Compliance
Neck
Language
Head
Neoplasms

Cite this

Radford, K. ; Woods, H. ; Lowe, D. ; Rogers, S. / A UK multi-centre pilot study of speech and swallowing outcomes following head and neck cancer. In: Clinical Otolaryngology & Allied Sciences. 2004 ; Vol. 29, No. 4. pp. 376-381.
@article{30968352d7f64f82aa6e70def5eee5b7,
title = "A UK multi-centre pilot study of speech and swallowing outcomes following head and neck cancer",
abstract = "Speech and swallowing are important components of health-related quality of life following head and neck cancer treatment. The aim of this study was to demonstrate the value of prospective multi-centre evaluation by Speech and Language Therapists and to compare health-related quality of life with speech and swallowing impairments. The University of Washington Head and Neck questionnaire version 4 (UW-QOL) and Therapy Outcome Measures (TOM) were rated before and 6 months after cancer treatment in 95 patients from 12 centres. There was deterioration in TOM scores at 6 months. Pretreatment UW-QOL swallowing was ranked equal first, with speech fourth. At 6 months speech was first and swallowing second. There were positive correlations between UW-QOL swallowing and TOM dysphagia and between UW-QOL speech and TOM laryngectomy, voice, phonology and dysarthria disorders. Both outcome measures are suitable for routine practice. Adaptation of TOM scales for use with head and neck cancer patients may improve sensitivity, validity and therapist compliance.",
author = "K. Radford and H. Woods and D. Lowe and S. Rogers",
year = "2004",
doi = "10.1111/j.1365-2273.2004.00823.x",
language = "English",
volume = "29",
pages = "376--381",
journal = "Clinical Otolaryngology and Allied Sciences",
issn = "0307-7772",
publisher = "Blackwell Publishing",
number = "4",

}

A UK multi-centre pilot study of speech and swallowing outcomes following head and neck cancer. / Radford, K.; Woods, H.; Lowe, D.; Rogers, S.

In: Clinical Otolaryngology & Allied Sciences, Vol. 29, No. 4, 2004, p. 376-381.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A UK multi-centre pilot study of speech and swallowing outcomes following head and neck cancer

AU - Radford, K.

AU - Woods, H.

AU - Lowe, D.

AU - Rogers, S.

PY - 2004

Y1 - 2004

N2 - Speech and swallowing are important components of health-related quality of life following head and neck cancer treatment. The aim of this study was to demonstrate the value of prospective multi-centre evaluation by Speech and Language Therapists and to compare health-related quality of life with speech and swallowing impairments. The University of Washington Head and Neck questionnaire version 4 (UW-QOL) and Therapy Outcome Measures (TOM) were rated before and 6 months after cancer treatment in 95 patients from 12 centres. There was deterioration in TOM scores at 6 months. Pretreatment UW-QOL swallowing was ranked equal first, with speech fourth. At 6 months speech was first and swallowing second. There were positive correlations between UW-QOL swallowing and TOM dysphagia and between UW-QOL speech and TOM laryngectomy, voice, phonology and dysarthria disorders. Both outcome measures are suitable for routine practice. Adaptation of TOM scales for use with head and neck cancer patients may improve sensitivity, validity and therapist compliance.

AB - Speech and swallowing are important components of health-related quality of life following head and neck cancer treatment. The aim of this study was to demonstrate the value of prospective multi-centre evaluation by Speech and Language Therapists and to compare health-related quality of life with speech and swallowing impairments. The University of Washington Head and Neck questionnaire version 4 (UW-QOL) and Therapy Outcome Measures (TOM) were rated before and 6 months after cancer treatment in 95 patients from 12 centres. There was deterioration in TOM scores at 6 months. Pretreatment UW-QOL swallowing was ranked equal first, with speech fourth. At 6 months speech was first and swallowing second. There were positive correlations between UW-QOL swallowing and TOM dysphagia and between UW-QOL speech and TOM laryngectomy, voice, phonology and dysarthria disorders. Both outcome measures are suitable for routine practice. Adaptation of TOM scales for use with head and neck cancer patients may improve sensitivity, validity and therapist compliance.

U2 - 10.1111/j.1365-2273.2004.00823.x

DO - 10.1111/j.1365-2273.2004.00823.x

M3 - Article

VL - 29

SP - 376

EP - 381

JO - Clinical Otolaryngology and Allied Sciences

JF - Clinical Otolaryngology and Allied Sciences

SN - 0307-7772

IS - 4

ER -